Abstract: A structural component for an aircraft, spacecraft or rocket has a ply of fiber reinforced polymer, a first carbon nanotube mat; and a metallic layer, wherein the carbon nanotube mat and the metallic layer are arranged on the ply of fiber reinforced polymer to form a hybrid lightning strike protection layer. A component for manufacturing such a structural component, a method for manufacturing a component of this type, a method for manufacturing a structural component and an aircraft or spacecraft with such a structural component are described.

Abstract: The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention, suppression or amelioration of a disease mediated by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes-related disorders, specifically type II diabetes, methods of their production, as well as methods of treatment or prevention of such diseases.

Abstract: The present invention relates to platelet-shaped zinc-magnesium pigments, wherein the platelet-shaped zinc-magnesium pigments comprise the 40.8 to 67.8 mol % of zinc, 32.2 to 59.2 mol % of magnesium and 0 to 7 mol % of Mn, Li, Be, Y, Sn, Al, Ti, Fe, Cu and mixtures thereof, based in each case on the total molar amount of the elements Zn, Mg, Mn, Be, Y, Li, Sn, Al, Ti, Fe and Cu, where the molar percentages add up to 100 mol %, and the median thickness h50 of the pigments is less than 1 ?m. The invention further relates to the use and production of these pigments.

Abstract: The present invention relates to a method for the production of a particle-containing aerosol, which includes comminutating a particle-containing cylinder. These aerosols are for example particularly suitable for use in the form of an aerosol stream in a coating process. The present invention further relates to particle-containing cylinders which can be dispersed and converted into aerosol form by simple methods.

Abstract: The invention relates to the use of a particle-containing powdered coating material in a coating method selected from the group consisting of cold gas spraying, flame spraying, high-speed flame spraying, thermal plasma spraying and non-thermal plasma spraying, wherein the particles have a relative deformability factor Vm of at most 0.1 and the relative deformability factor is defined according to Formula (I): V m = d D 50 , ( I ) wherein d is the average smallest thickness of the particles, measured vertical to and in the middle half of the longitudinal axis of the particles, and D50 is the average diameter of the volume-averaged particle-size distribution. The invention furthermore relates to a method for coating.

Abstract: The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, characterized in that at least one of R8, R9, R10, R11 is —ORa; for use in the treatment or prevention, suppression or amelioration of a disease mediated, by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes-related disorders, specifically type II diabetes, methods of their production, their use as a dietary supplement or functional food, as well as methods of treatment or prevention of such diseases.

Abstract: The invention relates to a suspension comprising a water-miscible, preferably aqueous, solvent, graphene flakes and at least one additive of the formula I cR(-Sp-W)x??(I), having the structural elements cR, Sp and W. The invention further relates to a process for producing the suspension, graphene flakes and the use thereof.

Abstract: The present invention relates to platelet-shaped zinc-magnesium pigments, wherein the platelet-shaped zinc-magnesium pigments comprise the 40.8 to 67.8 mol % of zinc, 32.2 to 59.2 mol % of magnesium and 0 to 7 mol % of Mn, Li, Be, Y, Sn, Al, Ti, Fe, Cu and mixtures thereof, based in each case on the total molar amount of the elements Zn, Mg, Mn, Be, Y, Li, Sn, Al, Ti, Fe and Cu, where the molar percentages add up to 100 mol %, and the median thickness h50 of the pigments is less than 1 ?m. The invention further relates to the use and production of these pigments.

Abstract: The present invention relates to platelet-shaped anticorrosion pigments, wherein the platelet-shaped zinc-magnesium alloy pigments have a composition comprising 25.1 to 76.85 mol % of Zn, 23 to 67.3 mol % of Mg, 0.15 to 7.6 mol % of Mn, Be, Y, Li, Sn and mixtures thereof, 0 to 5 mol % of Al, Ti, Fe, Cu and mixtures thereof, based in each case on the total molar amount of the elements Zn, Mg, Mn, Be, Y, Li, Sn, Al, Ti, Fe and Cu, where the molar percentages add up to 100 mol %. The invention further relates to the use and production of these pigments.

Abstract: The present invention relates to the use of a particle-containing powdered coating material, wherein the surface of the particles is at least partially covered with a coating additive, in cold gas spraying, flame spraying, high-speed flame spraying, thermal plasma spraying and non-thermal plasma spraying. Furthermore, the present invention relates to coating methods, in particular the above-named methods, using the powdered coating material according to the invention.

Abstract: The present invention relates to compounds of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment or prevention, suppression or amelioration of a disease mediated by the ROR gamma receptor in a subject in need thereof, in particular diabetes and diabetes-related disorders, specifically type II diabetes, methods of their production, as well as methods of treatment or prevention of such diseases.

Abstract: The invention relates to the use of a particle-containing powdered coating material in a coating method selected from the group consisting of cold gas spraying, flame spraying, high-speed flame spraying, thermal plasma spraying and non-thermal plasma spraying, wherein the particles have a relative deformability factor Vm of at most 0.1 and the relative deformability factor is defined according to Formula (I): V m = d D 50 , ( I ) wherein d is the average smallest thickness of the particles, measured vertical to and in the middle half of the longitudinal axis of the particles, and D50 is the average diameter of the volume-averaged particle-size distribution. The invention furthermore relates to a method for coating.

Abstract: The present invention relates to the use of a particle-containing powdered coating material, wherein an additive has been at least partially applied to the surface of the particles, in coating methods, in particular in cold gas spraying, flame spraying, high-speed flame spraying, thermal plasma spraying and non-thermal plasma spraying. Furthermore, the present invention relates to coating methods, in particular the above-named methods, using the powdered coating material according to the invention.

Abstract: The present invention relates to a method for applying a coating to a substrate using cold plasma, wherein particles provided with a polymer coating are fed into a cold plasma at less than 3,000 K and the particles activated by this are deposited on a substrate. The present invention furthermore relates to a substrate coating which can be obtained by the methods according to the invention. The present invention furthermore relates to the use of platelet-shaped particles with a polymer coating with an average thickness of less than 2 ?m in the coating of a substrate using a cold plasma.

Abstract: Particles colored with at least one colorant, where the colored glass particles are glass platelets with an average diameter of 1 to 500 ?m and the colorants at least include at least one of metallic nanoparticles and metal oxides. The glass platelets are planar and the colorants are present in a concentration from 1% to 55% by weight, based on the total weight of the colored glass platelets. The disclosure further relates to a method to a method for producing the colored glass particles and to the use thereof.

Abstract: The invention relates to a method and a device for applying a coating to a substrate, where a plasma jet of a low-temperature plasma is produced by conducting a working gas through an excitation zone. The plasma jet is directed at the substrate, and plate-shaped particles having an average thickness between 10 and 50,000 nanometers and a shape factor in a value range from 10 to 2000 are fed into the plasma jet. The plate-shaped particles are fed into the plasma jet by means of a carrier gas. The plasma jet is produced by exciting the working gas by means of an alternating voltage or a pulsed direct voltage.

Abstract: The invention relates to lamina-like iron pigments produced by deformation of carbonyl iron powder, the lamina-like iron pigments having a size distribution with a D50 value in a range of from 3 to 16 ?m and a size/thickness ratio in a range of from 2 to 50. The invention furthermore relates to a magnetorheological fluid which contains the lamina-like iron pigments according to the invention, as well as to a device which contains the magnetorheological fluid.

Abstract: The invention relates to a method for the fluid-phase synthesis of a polymer formed from n monomers.

Abstract: A process for producing a dispersion containing metal oxide nanoparticles in a liquid phase, wherein the process comprises the following steps: (a) atomization of a metal melt to give a metallic powder, (b) optionally deformation of the metallic powder obtained in step (a), (c) oxidation of the metallic powder obtained in step (a) or (b) to give a metal oxide powder, (d) comminution of the metal oxide powder obtained in step (c) in the presence of a liquid phase to give a dispersion whose metal oxide particles have a particle size d90,oxide of less than 300 nm. The invention further relates to a dispersion which can be obtained by the process of the invention.

Abstract: This invention relates to new formulated lipid particles (FLiPs) comprising at least one of a single or double stranded oligonucleotide, where the oligonucleotide has been conjugated to a lipophile and at least one of an emulsion or liposome to which the conjugated oligonucleotide has been aggregated, admixed or associated. These particles have surprisingly been shown to effectively deliver oligonucleotides to heart, lung and muscle where they effect gene silencing.